Allena Pharmaceuticals Financials

Allena Pharmaceuticals Stock Summary

Allena Pharmaceuticals competes with Cellectis. Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. On September 2, 2022, Allena Pharmaceuticals, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Allena Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 12 people.

Allena Pharmaceuticals Key Financial Ratios

Allena Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Allena Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Allena Pharmaceuticals over time and compare it to other companies across industries.

Allena Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Allena Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Allena Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allena Pharmaceuticals competition to find correlations between indicators driving Allena Pharmaceuticals's intrinsic value. More Info.Allena Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Allena Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Allena Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Allena Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Allena Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Allena Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Allena Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Allena Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.